1-5 of 5
Stéphane De Botton, MD
Close
Sort by
Journal Articles

Is Azacitidine (AZA) Really Effective in High Risk MDS Patients with Chromosome 7 Abnormalities (Abn 7)? Results of a Retrospective Study From the GFM and GESMD Registries

María Díez-Campelo, MD, PhD, Raphael Itzykson, Silvia M Rojas, Céline Berthon, MD, PhD, Elisa Luño, Odile Beyne-Rauzy, Jaime Perez-Oteyza, Norbert Vey, MD, PhD, Joan Bargay, Sophie Park, Teresa Cedena, Dominique Bordessoule, MD, PhD, Juan A Muñoz, Emmanuel Gyan, MD, PhD, Esperanza Such, Sorin Visanica, MD, Luis Benlloch, Stéphane de Botton, MD, PhD, Jesús M Hernández-Rivas, Shanti Ame, MD, Aspasia Stamatoullas, MD, Jacques Delaunay, MD, Celia Salanoubat, MD, Françoise Isnard, MD, Guillermo Sanz, Romain Guieze, MD, Consuelo Cañizo, MD, PhD, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1713.
https://doi.org/10.1182/blood.V120.21.1713.1713
Published: 2012
Journal Articles

Use of Clofarabine in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Adults: The French Experience

David Sibon, MD, PhD, Ana Berceanu, MD, David Ghez, MD, PhD, Frantz Foissac, Leila Kammoun, MD, Thorsten Braun, MD, Denis Caillot, MD, Mario Ojeda-Uribe, MD, Romain Guieze, MD, Céline Berthon, MD, Laurence Sanhes, MD, Bérengère Gruson, MD, Didier Bouscary, MD, PhD, Christian Recher, MD, PhD, Laure Stalnikiewicz, MD, Philippe Rousselot, MD, PhD, Emmanuel Raffoux, MD, PhD, Thomas Prebet, MD, PhD, Bruno Salles, MD, Stéphane de Botton, MD, PhD, Ambroise Marcais, MD, Felipe Suarez, MD, PhD, Olivier Hermine, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2623.
https://doi.org/10.1182/blood.V118.21.2623.2623
Published: 2011
Journal Articles

Treatment of High Risk MDS and AML Post-MDS with Azacytidine (AZA): Preliminary Results of the French ATU Program.

Claire Fabre, MD, Fatsiha Chermat, Laurence Legros, MD, Sophie Park, MD, François Dreyfus, MD, Françoise Isnard, MD, Florence Nowak, MD, Anne Marfaing, MD, Stéphane de Botton, MD, Marie-Pierre Noel, MD, Christophe Fruchart, MD, Thomas Prebet, MD, Norbert Vey, MD, Caroline Dartigeas, MD, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2006) 108 (11): 2664.
https://doi.org/10.1182/blood.V108.11.2664.2664
Published: 2006
Journal Articles

Treatment of Myelodysplastic Syndromes with del 5q before the Lenalidomide Era: The GFM Experience.

Charikleia Kelaidi, MD, Sophie Park, MD, Sabine Brechignac, MD, Lionel Mannone, MD, Norbert Vey, MD, Herve Dombret, MD, Lina Aljassem, MD, Aspasia Stamatoullas, MD, Lionel Adès, MD, Stéphane Giraudier, MD, Stéphane de Botton, MD, Béatrice Mahé, MD, Pascale Lepelley, MD, Françoise Picard, MD, Geneviève Leroux, MD, Marie-Thérèse Daniel, MD, Didier Bouscary, MD, François Dreyfus, MD, Pierre Fenaux, MD
Journal: Blood
Blood (2006) 108 (11): 2678.
https://doi.org/10.1182/blood.V108.11.2678.2678
Published: 2006
Journal Articles

Post-Remission Therapy with Imatinib and HAM Improve MRD before Tansplant for Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL): Results of the GRAALL AFR03 Study.

Thibaut Leguay, MD, Francis Witz, MD, Stéphane De Botton, MD, Jean Gabert, MD PHD, Jean-Michel Cayuela, MD PHD, Elizabeth Macintyre, MD PHD, Claude Preudhomme, MD, Nathalie Fegueux, MD, Xavier Thomas, MD, Jean-Yves Cahn, MD, Martine Escoffre, MD, Andre Delannoy, MD, Norbert Ifrah, MD, Herve Dombret, MD, Arnaud Pigneux, MD
Journal: Blood
Blood (2006) 108 (11): 1877.
https://doi.org/10.1182/blood.V108.11.1877.1877
Published: 2006